EBV-RELATED MALIGNANT NEOPLASM

Clinical trials for EBV-RELATED MALIGNANT NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new EBV-RELATED MALIGNANT NEOPLASM trials appear

Sign up with your email to follow new studies for EBV-RELATED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental vaccine aims to shield transplant patients from Cancer-Causing virus

Prevention Terminated

This early-stage trial is testing a new vaccine designed to prevent infections from Epstein-Barr virus (EBV) and the cancers it can cause. The study will enroll healthy volunteers and patients awaiting organ transplants, who are at higher risk for EBV-related cancers due to their…

Matched conditions: EBV-RELATED MALIGNANT NEOPLASM

Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention

Last updated Mar 24, 2026 12:03 UTC

EBV-RELATED MALIGNANT NEOPLASM

Get alerted when new EBV-RELATED MALIGNANT NEOPLASM trials appear

Experimental vaccine aims to shield transplant patients from Cancer-Causing virus